Editorial
Published on 17 Oct 2023
Editorial: Global excellence in inflammation pharmacology
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1307503
- 1,828 views
Type at least 3 characters
1,653 articles
Articles
Systematic Review
Published on 17 Oct 2023
A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1287320
- 3,903 views
- 3 citations
Original Research
Published on 13 Oct 2023
Evaluation of anti-inflammatory and immunomodulatory potential of Lawsone (2-hydroxy-1,4-naphthoquinone) using pre-clinical rodent model of rheumatoid arthritis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1279215
- 2,367 views
- 3 citations
Original Research
Published on 09 Oct 2023
Proteomic and single-cell analysis shed new light on the anti-inflammatory role of interferonβ in chronic periodontitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1232539
- 3,034 views
- 2 citations
Original Research
Published on 03 Oct 2023
Revealing the diagnostic value and immune infiltration of senescence-related genes in endometriosis: a combined single-cell and machine learning analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1259467
- 3,123 views
- 3 citations
Review
Published on 02 Oct 2023
Natural products modulate NLRP3 in ulcerative colitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1265825
- 4,712 views
- 12 citations
Systematic Review
Published on 28 Sep 2023
Anti-inflammatory and antioxidant activity of ursolic acid: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1256946
- 4,324 views
- 9 citations
Original Research
Published on 28 Sep 2023
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1239025
- 7,543 views
- 19 citations
Systematic Review
Published on 28 Sep 2023
Effects of metformin on acute respiratory distress syndrome in preclinical studies: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1215307
- 2,184 views
Original Research
Published on 26 Sep 2023
Alleviation of allergic conjunctivitis by (±)5(6)-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid in mice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1217397
- 2,633 views
Editorial
Published on 20 Sep 2023
Editorial: Big data for biomedical research of inflammatory diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1287616
- 1,084 views
- 2 citations
Review
Published on 20 Sep 2023
Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1238782
- 4,544 views
- 10 citations
Original Research
Published on 15 Sep 2023
Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1247800
- 3,298 views
- 6 citations
Review
Published on 13 Sep 2023
Chlorogenic acid: a review on its mechanisms of anti-inflammation, disease treatment, and related delivery systems
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218015
- 9,772 views
- 27 citations
Original Research
Published on 12 Sep 2023
Dipyridamole activates adenosine A2B receptor and AMPK/cAMP signaling and promotes myogenic differentiation of myoblastic C2C12 cells
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1247664
- 3,024 views
- 1 citation
Case Report
Published on 12 Sep 2023
Baricitinib treatment for refractory skin changes in POEMS syndrome: a case report
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1191158
- 1,427 views